News
February, 2010
Postdoctoral and Ph.D. Positions in Computational Chemistry at InhibOx, Oxford, UK
more...
Intelligensys and InhibOx Apply Proven Formulation Approaches to Improve Lead Discovery Efficiency
more...
December, 2009
InhibOx and Molport Join Forces to Deliver Integrated Lead Design and Delivery
more...
November, 2009
InhibOx announces important breakthrough in molecular similarity:
Chiral Shape Recognition (CSR)
more...
Successful DrugFinder collaboration with Oxford University Chemistry Department
discovers novel kinase inhibitors.
more...
September, 2009
Prof. W. Graham Richards discusses his latest book, “Spin-Outs”.
more...
InhibOx presents at 8th International Symposium on Carbonic
Anhydrases: “Computational approaches to the design of new carbonic
anhdydrase inhibitors”.
more...
InhibOx presents at ELRIG Drug Discovery 2009: “Harnessing
Modern Web Technologies for Virtual Screening.”
more...
August, 2009
InhibOx appoints Paul Davie to lead Commercial Growth.
more...
InhibOx collaborates with Lauras AS to advance its drug discovery projects.
more...
September, 2008
InhibOx and the National Foundation for Cancer Research announce the launch of DrugFinder,
a free virtual screening service.
more...
Dr. Garrett M. Morris joins InhibOx.
more...
March, 2008
Biochemical Institute, University of Kiel, joins EU DeZnIT consortium.
more....
October, 2007
European Union supports €3M Project to develop technology against a major therapeutically relevant
enzyme family.
more...